Perioperative chemo-immunotherapy (unspecified agents)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Perioperative chemo-immunotherapy (unspecified agents), covering 2026-01-21 to 2026-01-21. Get the full timeline:
Most recent: Clinical Trial Update: Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC [Phase 2]